Birmingham, West Midlands -- (SBWIRE) -- 01/24/2014 -- Value Penny Stocks issues special report on DARA Biosciences Inc (NASDAQ:DARA), Hanwha Solarone Co Ltd (NASDAQ:HSOL), FuelCell Energy Inc (NASDAQ:FCEL), Atossa Genetics Inc (NASDAQ:ATOS).
DARA Biosciences Inc (NASDAQ:DARA) ended its recent business day with the loss of -1.15% and closed at the price of $0.860 after opening at $0.82. The stock traded during its last trading session with the total volume of 2,950,406 shares, as compared to its average volume of 1.78 million shares. DARA BioSciences, Inc., a development stage biopharmaceutical company, develops and commercializes oncology treatment and supportive care pharmaceutical products in the United States. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups.
Has DARA Found The Bottom and Ready To Move Up? Find Out Here
Hanwha Solarone Co Ltd (NASDAQ:HSOL) remained among the day decliners and traded with volume of 2,928,921 shares in the last session, as compared to average volume of 2.31 million shares. In comparison with 52 week range of $0.86 - $5.70, it faced lowest price of $2.71 during the last trading session whereas its day highest price was $2.88. The company’s total market capitalization is $236.25 billion, along with 84.68 million shares outstanding. Hanwha Solarone Co., Ltd., an investment holding company, engages in the manufacture and sale of silicon ingots, silicon wafers, photovoltaic (PV) cells, and PV modules. It provides mono crystalline and multi crystalline silicon cells; PV module processing services; and construction services to build solar power systems.
Has HSOL Found The Bottom And Ready To Gain Momentum? Find Out Here
FuelCell Energy Inc (NASDAQ:FCEL) showed 2,882,635 shares in volume during the last trading session, while the average trading volume remained 398,490.00 shares. The stock kicked off its trading session at $2.90 and closed at $3.20 after mounting 5.96%. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation.
For How Long FCEL will Fight for Profitability? Read This Trend Analysis report
Atossa Genetics Inc (NASDAQ:ATOS) stock traded during its last trading session with the total traded volume of 3,109,261 shares versus its average volume of 398,490.00 shares. The company opened its trade at the price of $2.90 and its closing price was $3.20 after gaining 5.96% for the day. Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States.
Why Should Investors Buy ATOS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)